MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc. is a pioneering force in the biotechnology sector, dedicated to the development and commercialization of first-in-class drugs. With a focus on targeted therapy and immuno-oncology, MAIA Biotechnology aims to significantly improve and extend the lives of individuals battling cancer. The company's innovative approach involves novel mechanisms of action, positioning it at the forefront of cancer treatment advancements.

Located at 444 West Lake Street, Suite 1700, Chicago, Illinois 60606, US, MAIA Biotechnology leverages a diversified portfolio of assets to control risk and enhance opportunities for success. This includes a variety of compounds with potential activity in multiple tumor types. Through a dedicated, R&D-focused subsidiary company model, MAIA ensures focused support for each drug candidate while maintaining a lean, capital-efficient operating structure.

MAIA Biotechnology, Inc. is committed to advancing promising agents into human clinical trials and creating a strong value proposition within the pharmaceutical landscape. The company is strategically positioned to drive innovation and make a lasting impact on cancer treatment. We invite the management team at MAIA Biotechnology to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.